03:56 PM EST, 12/05/2025 (MT Newswires) -- Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.5%.

The iShares Biotechnology ETF (IBB) shed 0.6%.

In corporate news, Novo Nordisk ( NVO ) has lost an Indian court case over whether Dr. Reddy's Laboratories (RDY) can make and export generic versions of its diabetes and weight-loss drugs, news outlets reported. Novo shares were down 0.2%, and Dr. Reddy's rose 0.2%.

Humana (HUM) shares rose 1.9% after Jefferies upgraded the stock to buy from hold and boosted its price target to $313 from $253.

Edwards Lifesciences ( EW ) has reiterated its long-term business outlook on a growing portfolio of structural heart therapies, which appears achievable, RBC Capital Markets said Thursday. RBC raised its price target to $100 from $95 and maintained its outperform rating. Edwards shares rose 0.5%.

Conmed ( CNMD ) fell 9% after the firm said it plans to exit its gastroenterology product lines as part of a portfolio optimization strategy. As a result of the exit, the firm said it expects an EPS dilution of $0.45 to $0.55 in 2026.